[
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 183,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 130
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 66,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 195,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 64
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 119,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 90,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 157
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 80,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 66
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": 73
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 197
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 57
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 86,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 112
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 117,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 137
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 163
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 152
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 81
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 54
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 87,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 190
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 98,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 57,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 88
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 105,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 132,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 102,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 198,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 54,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": 135
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 50,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 63
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 193,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 174,
    "actual_cumulative_drug_dose": 86
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 78
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 157,
    "actual_cumulative_drug_dose": 106
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 150,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 188,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 160
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 68,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 116
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 64,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 134,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 154,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 143,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 129
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 187
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 94
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 53,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 165
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 101,
    "actual_cumulative_drug_dose": 192
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 191,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 93
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 138
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 200
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 97,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 151,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 145,
    "actual_cumulative_drug_dose": 96
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 121,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 62,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 63,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 91,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 58,
    "actual_cumulative_drug_dose": 115
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 175,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 122,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 146
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 90
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 72,
    "actual_cumulative_drug_dose": 79
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 140
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 139,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 99
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": 105
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 65,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 185,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 196,
    "actual_cumulative_drug_dose": 178
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 162,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": 89
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 53
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 70,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 73,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 69,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 173
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 177,
    "actual_cumulative_drug_dose": 131
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 181
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 170,
    "actual_cumulative_drug_dose": 72
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 177
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 60,
    "actual_cumulative_drug_dose": 109
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 147,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 169,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 112,
    "actual_cumulative_drug_dose": 107
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 166,
    "actual_cumulative_drug_dose": 65
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 121
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 153,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 104
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 118,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 113
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 167
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 68
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 168,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 182,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 85,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 79,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 110,
    "actual_cumulative_drug_dose": 77
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 81,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 193
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 172,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 94,
    "actual_cumulative_drug_dose": 132
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 146,
    "actual_cumulative_drug_dose": 198
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 127,
    "actual_cumulative_drug_dose": 50
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 135,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 71
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 148
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 123
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 140,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 108,
    "actual_cumulative_drug_dose": 154
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 99,
    "actual_cumulative_drug_dose": 159
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 88,
    "actual_cumulative_drug_dose": 136
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 78,
    "actual_cumulative_drug_dose": 80
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 124
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 174
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 67
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 110
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 144,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 158
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 96,
    "actual_cumulative_drug_dose": 153
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 100,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 56,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 141
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 71,
    "actual_cumulative_drug_dose": 83
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 84
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 67,
    "actual_cumulative_drug_dose": 101
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 176
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 184,
    "actual_cumulative_drug_dose": 103
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 113,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 138,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 84,
    "actual_cumulative_drug_dose": 164
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 180
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 155,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 142
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 126
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 142,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 183
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 93,
    "actual_cumulative_drug_dose": 166
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 125,
    "actual_cumulative_drug_dose": 175
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 179,
    "actual_cumulative_drug_dose": 95
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 106,
    "actual_cumulative_drug_dose": 91
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 107,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 186,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 126,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 141,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 167,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 144
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 171,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 83,
    "actual_cumulative_drug_dose": 143
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 165,
    "actual_cumulative_drug_dose": 102
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 95,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 58
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 184
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 145
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 139
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 60
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": 92
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 114
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 152,
    "actual_cumulative_drug_dose": 125
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": 117
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 118
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 178,
    "actual_cumulative_drug_dose": 186
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 123,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 92,
    "actual_cumulative_drug_dose": 120
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 169
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 62
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 134
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 148,
    "actual_cumulative_drug_dose": 98
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 82,
    "actual_cumulative_drug_dose": 162
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 115,
    "actual_cumulative_drug_dose": 59
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 158,
    "actual_cumulative_drug_dose": 97
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 168
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 187,
    "actual_cumulative_drug_dose": 51
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 197,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 176,
    "actual_cumulative_drug_dose": 161
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 199,
    "actual_cumulative_drug_dose": 199
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 109,
    "actual_cumulative_drug_dose": 69
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 164,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 52,
    "actual_cumulative_drug_dose": 52
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 137,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 185
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 191
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 181,
    "actual_cumulative_drug_dose": 179
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 114,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 161,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/kg",
    "prescribed_cumulative_drug_dose": 116,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 156,
    "actual_cumulative_drug_dose": 195
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 82
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 128,
    "actual_cumulative_drug_dose": 196
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": 55
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 180,
    "actual_cumulative_drug_dose": 100
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "239766",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 149,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 131,
    "actual_cumulative_drug_dose": 150
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 130,
    "actual_cumulative_drug_dose": 85
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 103,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 89,
    "actual_cumulative_drug_dose": 188
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 75,
    "actual_cumulative_drug_dose": 56
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 136,
    "actual_cumulative_drug_dose": 108
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 55,
    "actual_cumulative_drug_dose": 127
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "239766",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 51,
    "actual_cumulative_drug_dose": 119
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 124,
    "actual_cumulative_drug_dose": 76
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 133
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": null,
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": null,
    "prescribed_cumulative_drug_dose": 76,
    "actual_cumulative_drug_dose": 128
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": null,
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 200,
    "actual_cumulative_drug_dose": 75
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 163,
    "actual_cumulative_drug_dose": 122
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 147
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 59,
    "actual_cumulative_drug_dose": 149
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 111,
    "actual_cumulative_drug_dose": 156
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Pembrolizumab",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 87
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "278936",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "278936",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 61
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 194,
    "actual_cumulative_drug_dose": 111
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/m2",
    "prescribed_cumulative_drug_dose": 74,
    "actual_cumulative_drug_dose": 74
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 77,
    "actual_cumulative_drug_dose": 155
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "987654",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 189,
    "actual_cumulative_drug_dose": 170
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Necitumumab",
    "drug_reference_identifier": null,
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 182
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 190,
    "actual_cumulative_drug_dose": 172
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Pexidartinib",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": null,
    "actual_cumulative_drug_dose": 151
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Cell-based",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "278936",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 61,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": null,
    "drug_name": null,
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 120,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Copanlisib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": null,
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 192,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": null,
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 160,
    "actual_cumulative_drug_dose": 194
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "ug/m2",
    "prescribed_cumulative_drug_dose": 133,
    "actual_cumulative_drug_dose": 171
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Immune checkpoint inhibitors",
    "drug_name": "Gilteritinib",
    "drug_reference_identifier": "987654",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "IU/kg",
    "prescribed_cumulative_drug_dose": 104,
    "actual_cumulative_drug_dose": null
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8756456",
    "drug_reference_database": "RxNorm",
    "immunotherapy_drug_dose_units": "g/m2",
    "prescribed_cumulative_drug_dose": 159,
    "actual_cumulative_drug_dose": 189
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Other immunomodulatory substances",
    "drug_name": "Selumitinib",
    "drug_reference_identifier": "8836851",
    "drug_reference_database": "PubChem",
    "immunotherapy_drug_dose_units": "cells/kg",
    "prescribed_cumulative_drug_dose": 173,
    "actual_cumulative_drug_dose": 70
  },
  {
    "program_id": null,
    "submitter_donor_id": null,
    "submitter_treatment_id": null,
    "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
    "drug_name": "Belantamab",
    "drug_reference_identifier": "4459876",
    "drug_reference_database": "NCI Thesaurus",
    "immunotherapy_drug_dose_units": "mg/m2",
    "prescribed_cumulative_drug_dose": 129,
    "actual_cumulative_drug_dose": 105
  }
]
